Nomura Asset Management CO LTD Axsome Therapeutics, Inc. Transaction History

Nomura Asset Management CO LTD

  • $37.3 Billion
  • Q3 2025
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$100.39 - $129.29 $0 - $0
0 New
0 $0
Q2 2025

Aug 11, 2025
BUY
$95.65 - $116.49 $0 - $0
0 New
0 $0
Q1 2025

May 12, 2025
BUY
$80.05 - $137.75 $0 - $0
0 New
0 $0
Q1 2024

May 13, 2024
BUY
$69.39 - $97.64 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024
BUY
$57.42 - $83.61 $0 - $0
0 New
0 $0
Q3 2023

Nov 03, 2023
BUY
$69.25 - $82.21 $0 - $0
0 New
0 $0
Q2 2023

Aug 14, 2023
BUY
$58.41 - $90.35 $0 - $0
0 New
0 $0
Q2 2022

Jan 10, 2025
BUY
$21.74 - $46.75 $0 - $0
0 New
0 $0
Q2 2022

Aug 12, 2022
BUY
$21.74 - $46.75 $0 - $0
0 New
0 $0
Q1 2022

Jan 10, 2025
BUY
$23.7 - $41.39 $0 - $0
0 New
0 $0
Q1 2022

May 13, 2022
BUY
$23.7 - $41.39 $0 - $0
0 New
0 $0
Q4 2021

Jan 10, 2025
BUY
$30.7 - $43.36 $0 - $0
0 New
0 $0
Q4 2021

Feb 01, 2022
BUY
$30.7 - $43.36 $0 - $0
0 New
0 $0
Q3 2021

Nov 12, 2021
SELL
$19.91 - $68.26 $0 - $0
0 Closed
0 $0
Q2 2021

Jan 10, 2025
BUY
$50.63 - $73.5 $0 - $0
0 New
0 $0
Q2 2021

Aug 06, 2021
BUY
$50.63 - $73.5 $0 - $0
0 New
0 $0
Q1 2021

Jan 10, 2025
BUY
$55.91 - $81.44 $0 - $0
0 New
0 $0
Q1 2021

May 14, 2021
BUY
$55.91 - $81.44 $0 - $0
0 New
0 $0
Q4 2020

Jan 10, 2025
BUY
$66.31 - $86.52 $0 - $0
0 New
0 $0
Q4 2020

Feb 12, 2021
BUY
$66.31 - $86.52 $0 - $0
0 New
0 $0
Q3 2020

Nov 12, 2020
BUY
$68.34 - $85.84 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020
BUY
$49.87 - $98.69 $0 - $0
0 New
0 $0
Q1 2020

May 14, 2020
BUY
$41.2 - $101.31 $0 - $0
0 New
0 $0
Q4 2019

Feb 13, 2020
BUY
$16.71 - $106.24 $0 - $0
0 New
0 $0

Others Institutions Holding AXSM

# of Institutions
414
Shares Held
36.8M
Call Options Held
752K
Put Options Held
567K
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $5.99B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email